Loading interface...

Benidin Trio 12.5 Tablet

Manufactured byLLOYD HEALTHCARE PVT LTD
ContainsBenidipine (4 mg) + Chlorthalidone (12.5 mg) + Telmisartan (40 mg)
Description
Benidin Trio 12.5 Tablet is a medicine that consists of Benidipine, Chlorthalidone and Telmisartan. It is an anti-hypertensive medicine used for the treatment of high blood pressure. This medicine works by relaxing your blood vessels, making the blood flow better with less effort, thus lowering your blood pressure. This will reduce your risk of having a heart attack (a blockage of blood flow to the heart muscle) or a stroke (a condition that causes damage to the brain from interruption of its blood supply) by making it easier for your heart to pump blood around your body. Benidin Trio 12.5 Tablet shows some common side effects like swelling in your ankles or feet, back pain, headache, nausea, diarrhoea, and stomach pain. Most of these are temporary and usually resolve with time. Benidin Trio 12.5 Tablet can also cause sleepiness and dizziness, so you should not drive or do any activity that requires mental focus after taking this medicine. Avoid consuming alcohol with this medicine as it can worsen dizziness. Benidin Trio 12.5 Tablet can be taken with or without food. The dose will be decided by your doctor, depending on your blood pressure levels. Do not stop using this medicine without consulting your doctor as abrupt discontinuation may worsen your condition. Benidin Trio 12.5 Tablet is not recommended for use if you are allergic to it. If you have any pre-existing kidney or liver problems, or other medical conditions, inform your doctor about them. Inform your doctor about all medicines and supplements you are taking as this medicine can interact with them and can cause side effects. Benidin Trio 12.5 Tablet is not recommended for use in children below 18 years of age. Consult your doctor if you are pregnant, or are breastfeeding. You should maintain a strict exercise and diet regimen along with this medicine to get the best possible effect.

Side effects

Major & minor side effects for Benidin Trio 12.5 Tablet

  • Dizziness
  • Headache
  • Constipation or diarrhea
  • Skin rash
  • Nausea or vomiting
  • Lightheadedness
  • Low blood pressure
  • Loss of appetite
  • Blurred vision
  • Restlessness
  • Abdominal pain
  • Back pain
  • Muscle pain
  • Weakness
  • Difficulty or painful urination
  • Increased heartbeat

Uses of Benidin Trio 12.5 Tablet

What is it prescribed for?

  • Hypertension
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of Benidin Trio 12.5 Tablet can be observed within 2 hours after intake.
  • How long do the effects of this medicine last?
    The amount of time for which the Benidin Trio 12.5 Tablet remains active in the body is not known.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with Benidin Trio 12.5 Tablet due to the increased risk of dizziness, fainting, and very low blood pressure levels. It is advised that you do not perform any activity that requires high mental alertness like driving vehicles or operating machines if you experience any of these symptoms.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for Benidin Trio 12.5 Tablet.
  • Can this medicine be taken during pregnancy?
    Benidin Trio 12.5 Tablet is not recommended for use in pregnancy as it may harm your foetus. Consult your doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    Benidin Trio 12.5 Tablet is known to pass into breastmilk. This medicine may decrease milk production in lactating mothers, lower the heart rate (bradycardia) in infants, and also cause dehydration in your infant. Consult your doctor if you are breastfeeding before taking this medicine.

Allergy

Avoid taking Benidin Trio 12.5 Tablet if you are allergic to benidipine, chlorthalidone, telmisartan or any of the contents present in this tablet. Seek immediate medical attention if you experience symptoms such as skin rash, hives (painful eruptions that sting), swelling (face, lips, tongue, etc.), breathing difficulty, etc.

Aliskiren

It is not recommended to take Benidin Trio 12.5 Tablet and Aliskiren (used in the treatment of high blood pressure) together as this may lead to kidney damage, high blood pressure and hyperkalemia (high potassium levels in the blood). It may also cause other undesirable effects such as irregular heartbeat, muscle paralysis, heart attack, etc. This risk is especially higher in old people and if you have diabetes and kidney problems.

Anuria

Benidin Trio 12.5 Tablet is not recommended if you have anuria (a condition where the kidney is unable to produce urine), as it may cause kidney damage and water retention in your body.

Severe kidney disease

Benidin Trio 12.5 Tablet is excreted through the kidneys. It is not recommended if you have severe kidney problems. This medicine accumulates in the kidneys and can lead to other undesirable effects, thus worsening your condition.

Severe liver disease

Benidin Trio 12.5 Tablet is absorbed and broken down in the liver. Taking this medication while having liver problems, will further worsen your condition.
Warnings for special population

Pregnancy

Benidin Trio 12.5 Tablet is not recommended for use in pregnancy as it may harm your foetus. Consult your doctor before taking this medicine.

Breast-feeding

Benidin Trio 12.5 Tablet is known to pass into breastmilk. This medicine may decrease milk production in lactating mothers, lower the heart rate (bradycardia) in infants, and also cause dehydration in your infant. Consult your doctor if you are breastfeeding before taking this medicine.
General warnings

Use in children

Benidin Trio 12.5 Tablet is not recommended for use in anyone less than 18 years of age since the safety and efficacy data is not available.

Use in elderly

Benidin Trio 12.5 Tablet should be used with caution in elderly people due to the increased risk of blood pressure falling to unsafe levels. Regular monitoring of blood pressure levels is necessary while using this medicine. Your doctor may adjust the dose of this medicine based on the clinical condition and therapeutic response.

Hypotension

Hypotension is the condition where your blood pressure is lower than normal. Benidin Trio 12.5 Tablet is not recommended for use if you have hypotension (low blood pressure) as it will further decrease your blood pressure which can be dangerous. Also, if you are taking diuretics (water pills or medicines that increase the amount of urine you produce) or are being treated for volume depletion (loss of fluids in the body due to severe diarrhoea/vomiting, burns, kidney problems, etc), this medicine is not suitable for you.

Hyperkalaemia

Benidin Trio 12.5 Tablet may lead to hyperkalaemia (a condition where potassium levels in your blood get too high). This may cause side effects such as cardiac rhythm irregularities. It is advised to avoid potassium-rich foods (potatoes, bananas) and other medicines that may increase potassium levels (ACE inhibitors and potassium supplements) during treatment with this medicine.

Liver disease

Benidin Trio 12.5 Tablet should be used with extreme caution if you have liver problems due to the increased risk of severe side effects. Your doctor may adjust the dose of this medicine or may suggest a suitable alternative as needed based on your condition. Also, your doctor may suggest tests to monitor your liver functioning if required while you are on treatment with this medicine.

Volume and electrolyte disturbances

Benidin Trio 12.5 Tablet may alter the blood volume and electrolyte levels. This may cause dizziness, dry mouth, and acid-base imbalance (abnormality in the human body to balance between acid and base). This risk is especially higher if you have kidney or liver problems. Your blood pressure and electrolyte levels will be closely monitored by your doctor while you are on this medication.

Kidney diseases

Benidin Trio 12.5 Tablet should be used with caution if you have kidney problems due to the increased risk of worsening your condition. Your doctor may adjust the dose of this medicine or may suggest a suitable alternative as needed based on your condition. Also, your doctor may suggest tests to monitor your kidney functioning if required while you are on treatment with this medicine.

Driving or operating machines

Benidin Trio 12.5 Tablet may cause symptoms such as drowsiness, blurred vision, or dizziness. It is advised that you do not perform any activity that requires high mental alertness like driving vehicles or operating heavy machines during treatment with this medicine.

Missed Dose

Take the missed dose of Benidin Trio 12.5 Tabletas soon as you remember. If it is almost time for your next dose, skip the missed dose and resume at the scheduled time. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment if you suspect that you might have taken an overdose of Benidin Trio 12.5 Tablet.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with Benidin Trio 12.5 Tablet due to the increased risk of dizziness, fainting, and very low blood pressure levels. It is advised that you do not perform any activity that requires high mental alertness like driving vehicles or operating machines if you experience any of these symptoms.
Interaction with Medicine

Dexamethasone

Antihypertensives

Insulin

Nonsteroidal anti-inflammatory medicines

Itraconazole

Amiodarone

Cisapride

Cimetidine

Rifampicin

Lithium

Disease interactions

Cardiogenic shock

Benidin Trio 12.5 Tablet is not recommended for use in case of a cardiogenic shock (a condition where the heart suddenly stops pumping enough blood to meet the demands of your body) due to the increased risk of a heart attack. The heart function will be closely monitored in such cases.

Hyperuricemia

Benidin Trio 12.5 Tablet should be used with caution if you have hyperuricaemia (a condition that causes increased uric acid levels in your blood). This medicine decreases the excretion of uric acid and increases its level in your blood. This in turn affects different organs of your body.

Diabetes

Benidin Trio 12.5 Tablet should be used with caution if you have Diabetes mellitus (a condition that results in high blood sugar levels in the blood) because of the increased risk of altered blood sugar levels. You will be advised to closely monitor your blood sugar levels while taking this medicine.

Hyperlipidaemia

Benidin Trio 12.5 Tablet should be used with caution in hyperlipidaemia (a condition in which there are high levels of fat particles (cholesterol) in the blood) because it worsens the condition. Your doctor will closely monitor your cholesterol and triglyceride levels while you are on treatment with this medication.

Liver disease

Benidin Trio 12.5 Tablet should be used with extreme caution if you have liver problems due to the increased risk of severe side effects. Your doctor may adjust the dose of this medicine or may suggest a suitable alternative as needed based on your condition.

Congestive heart failure

Congestive heart failure is a condition in which your heart does not pump enough blood to meet the demands of your body. Taking Benidin Trio 12.5 Tablet in this condition may increase the risk of heart attack. Your doctor will closely monitor your heart function while you are taking this medicine.
Food interactions
Grapefruit juice enhances the absorption of Benidin Trio 12.5 Tablet in your body, thus increasing its level in your blood. This may lead to side effects such as dizziness, headache, swelling of hands and feet, etc.
Lab interactions
Information not available.
Take Benidin Trio 12.5 Tablet with or without food. Do not take in larger amounts than prescribed. It may cause dizziness. Get up slowly when rising from a sitting or lying down position. Avoid driving vehicles or operating machines after taking this medicine. This medicine may cause dehydration therefore drink plenty of fluids and inform your doctor if you develop extreme thirst, muscle weakness or a very dry mouth. Keep the medicine away from the reach of children and pets. Ensure that the unused medicine is disposed of properly. Do not self-medicate or stop taking the medicine on your own unless directed by your doctor. Do not crush, break or chew the tablet in your mouth.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Chlorthalidone increases the excretion of water and sodium from the kidneys. This helps in lowering the blood pressure and oedema (also known as fluid retention; is a build-up of fluid in your body that causes swelling). Benidipine and Telmisartan both relax the blood vessels, which improves blood flow and reduces blood pressure levels. Their combination is thus effective in treating hypertension.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Thiazide diuretics, Calcium channel blocking agents, Angiotensin receptor blockers, Antihypertensive combinations

Schedule

Schedule H

Drugs, H., 2021. Chlorthalidone: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 24 September 2021].

https://medlineplus.gov/druginfo/meds/a682342.html>

Drugs.ncats.io. 2021. NCATS Inxight: Drugs — BENIDIPINE HYDROCHLORIDE. [online] Available at: < [Accessed 23 September 2021].

https://drugs.ncats.io/drug/0A6746FWDL>

Ohara-ch.co.jp. 2021. [online] Available at: < [Accessed 23 September 2021].

https://www.ohara-ch.co.jp/appendix/pdf/inc03/benidipineHydrochloride8T-SIE.pdf>

Drugs, H., 2021. Telmisartan: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 23 September 2021].

https://medlineplus.gov/druginfo/meds/a601249.html>

Medicines.org.uk. 2021. Micardis 20 mg/40 mg/80 mg tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 23 September 2021].

https://www.medicines.org.uk/emc/medicine/27835>

2021. benidipine | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY. [online] Available at: <https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10159> [Accessed 23 September 2021].

https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10159Guidetopharmacology.org.

Cdsco.gov.in. 2021. [online] Available at: < [Accessed 24 September 2021].

https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadCommitteeFiles/MOMCardio.pdf>

Pubchem.ncbi.nlm.nih.gov. 2021. Telmisartan. [online] Available at: < [Accessed 2 August 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/65999>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 19 Oct 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.